3/21/2025Huadong Medicine's HDM1002 Advances to Phase III Clinical Trials

3/21/2025AZ's Calquence (Acalabrutinib) Receives New Approval in China for Firs...

3/21/2025Gilead's Trodelvy Receives Second Approval in China

3/21/2025Hengrui's Ivarmacitinib Secures First Approval in China for Ankylosing...

3/21/2025Henlius' HER2-Targeting Antibody HLX22 Granted FDA Orphan Drug Designa...

3/21/2025Dizal's Golidocitinib in Combo with Anti-PD-1 Shows Promise in IO Resi...

3/21/2025Innovent and Hutchmed's FRUSICA-2 Study Achieves Primary Endpoint

3/20/2025Grand Pharma Advances Phase III Trial of ITM-11 in China

3/19/2025Visirna's VSA001 Achieves Positive Phase III Results in Treating FCS

3/19/2025CSPC Initiates Phase 3 Trial of SYS6010 for EGFR-Mutant NSCLC Patients

3/19/2025Hengrui Initiates Phase 2/3 Trial Combining SHR-A2102 and Adebrelimab ...

3/17/2025Innovent Launches GLORY-3: A Phase 3 Head-to-Head Study of Mazdutide v...

3/17/2025Visirna Announce Positive Topline Results from Phase 3 Trial of Ploza...

3/17/2025SinoCellTech Advances PD-1/VEGF Bispecific SCTB14 into Phase 2/3 for E...

3/17/2025BeiGene and Amgen Launch Phase 1 Trial of Tarlatamab + YL201 in China

3/14/2025Innovent's IBI311 Becomes First Chinese-Made IGF-1R Antibody Approved ...

3/14/2025Zai Lab/Pfizer's BLA for Tivdak Accepted in China

3/14/2025Pyrotech's PTT-936 Gains Approval for Clinical Trials in China for Adv...

3/14/2025Roche's Itovebi (Inavolisib) Wins Approval in China for Advanced Breas...

3/13/2025AskBio Receives FDA Regenerative Medicine Advanced Therapy Designation...

3/12/2025Novartis' Cosentyx Receives Fifth Indication Approval in China for Hid...

3/12/2025Pfizer's PD-L1 Targeting ADC Receives Clinical Trial Approval in China

3/12/2025CSPC Advances Phase II Trial of Nectin-4 ADC SYS6002 for Advanced HNSC...

3/12/2025Akeso Initiates Phase III Trial of Ivonescimab Plus Chemotherapy for m...

3/11/2025Chinese Scientists Develop Potential Vaccine to Prevent Stroke and Hea...

3/11/2025MindRank's AI-Designed Dual Kinase Inhibitor MRANK-106 Receives FDA IN...

3/11/2025Pfizer's Elrexfio Receives Conditional Approval in China for Advanced ...

3/11/2025RockRoc Secures Pre-A+ Financing to Advance Macrophage-Based Cancer Th...

3/11/2025InnoCare Presents Promising Phase II Data on ICP-488 for Psoriasis

3/11/2025TYK Medicines Announces Pivotal Phase II Trial of TY-9591 Vs Osimertin...

Page:6/14 Total number of articles:418: [First][<<] [4] [5] [6] [7] [8] [>>] [End]